Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Spezial Report: NASDAQ-FinTech mit 3.000% Wachstum und 500% Kurs-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 27.02.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
27.02.23AppHarvest announces closing of public offering of common stock and full exercise of underwriters' option to purchase additional shares182MOREHEAD, Ky., Feb. 27, 2023 (GLOBE NEWSWIRE) -- AppHarvest, Inc. (NASDAQ: APPH, APPHW), a sustainable food company, public benefit corporation and Certified B Corp building some of the world's largest...
► Artikel lesen
27.02.23VERSES Announces Convertible Debenture Financing of up to C$5,000,000369VANCOUVER, British Columbia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- VERSES Technologies Inc. (NEO:VERS) (OTCQX:VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in the next generation...
► Artikel lesen
27.02.23Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger218Combined company will have commercial products and a library of development candidates, two of which are clinical stageWill be under the leadership of DMK CEO, Dr. Ebrahim (Eboo) Versi MD, PhDLead development...
► Artikel lesen
27.02.23Nasdaq, Inc.: Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 15, 2023212NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 15, 2023, short interest in 3,455 Nasdaq Global MarketSM securities totaled 9,937,951,277 shares compared with...
► Artikel lesen
27.02.23Safe Orthopaedics: Effective date of the reverse split and first listing of the new consolidated shares400Effective date of the reverse split and first listing...
► Artikel lesen
27.02.23Stellantis N.V.: Stellantis Announces Strategic Copper Investment in Argentina, Reinforcing Commitment to Reaching Carbon Net Zero by 2038324Stellantis Announces Strategic Copper Investment in Argentina, Reinforcing Commitment to Reaching Carbon Net Zero by 2038 $155 million investment in McEwen Copper helps Stellantis secure projected copper...
► Artikel lesen
27.02.23Eimskipafelag Islands hf.: Candidates to the Board of Directors and 2023 AGM's final agenda268Enclosed is information on candidates to the Board of Directors of Eimskipafélag Íslands hf. to be elected at the Annual General Meeting 9 March 2023. Deadline for declaring candidacy has passed. According...
► Artikel lesen
27.02.23Atrion Corporation: Atrion Reports Fourth Quarter and Full Year 2022 Results371ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022. Revenues for the...
► Artikel lesen
27.02.23Chinook Therapeutics, Inc.: Chinook Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates374SEATTLE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for...
► Artikel lesen
27.02.23Inari Medical, Inc.: Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results580IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous...
► Artikel lesen
27.02.23FibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2022 Financial Results387Topline Data from Five Pivotal Phase 3 Trials in 2023Total Company Revenue $140.7 Million in 2022Continued Strong Roxadustat Volume Growth in China SAN FRANCISCO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- FibroGen...
► Artikel lesen
27.02.23Denali Therapeutics Inc.: Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights560SOUTH SAN FRANCISCO, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross...
► Artikel lesen
27.02.23Vaxcyte, Inc.: Vaxcyte Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update559-- Company Received U.S. Food and Drug Administration (FDA) Clearance of VAX-24 Infant Investigational New Drug (IND) Application and Expects to Initiate Phase 2 Study in Second Quarter 2023 -- -- Topline...
► Artikel lesen
27.02.23Progyny, Inc. Announces Fourth Quarter 2022 Results473Reports Full Year Revenue of $786.9 Million, Reflecting 57% GrowthReports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, RespectivelyIssues Financial Guidance...
► Artikel lesen
27.02.23Dril-Quip, Inc. Announces Fourth Quarter and Full Year 2022 Results451Fourth quarter and full year revenue increase double digits year-over-yearSignificant progress made along operational excellence initiativesCompany provides fiscal 2023 financial outlook HOUSTON, Feb....
► Artikel lesen
27.02.23TaskUs Holdings, Inc.: TaskUs Announces Fiscal Fourth Quarter and Full Year 2022 Results588FY 2022 Revenue and Adjusted EBITDA Above Most Recent OutlookOver 26% Revenue Growth in FY 2022Added 40 Clients in FY 2022Number of Clients over $1 Million in Revenue Increased by 19% in FY 2022; Number...
► Artikel lesen
27.02.23EverQuote, Inc.: EverQuote Announces Fourth Quarter and Full Year 2022 Financial Results444Fourth Quarter Revenue of $88.3 millionFourth Quarter Variable Marketing Margin of $29.1 millionFull Year Revenue of $404.1 millionFull Year Variable Marketing Margin of $128.3 million CAMBRIDGE, Mass....
► Artikel lesen
27.02.23Revolution Medicines, Inc.: Revolution Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Update on Corporate Progress525Early clinical data on RMC-6236 provided in support of RAS(ON) Inhibitor platform validation Additional data releases for RMC-6236 (RASMULTI) and RMC-6291 (KRASG12C) expected in 2023 RMC-9805 (KRASG12D)...
► Artikel lesen
27.02.23Zoom Video Communications, Inc.: Zoom Video Communications Reports Fourth Quarter and Fiscal Year 2023 Financial Results223Fourth quarter total revenue of $1,117.8 million, up 4% year over year as reported and 6% in constant currency; full fiscal year total revenue of $4,393.0 million, up 7% year over year as reported and...
► Artikel lesen
27.02.23SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance534SANTA CLARA, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
► Artikel lesen
Seite:  Weiter >>